SN
Sandhya Nandiraju
About Sandhya Nandiraju
Data last updated:
Sandhya Nandiraju is a Whole-Time Director at Clinsync Clinical Research Private Limited (since 2018), Director at Atisa Life Sciences Private Limited (since 2025) and Director at Serind Pharma Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹15.95 Cr; the largest is Clinsync Clinical Research Private Limited at ₹15.75 Cr (FY 2025). Earlier, Sandhya Nandiraju was a Designated Partner at Avidia Pharma Labs Llp (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Clinsync Clinical Research Private Limited U73200TG2011PTC073413 | Whole-Time Director | 08 Jan 2018 | 2011 | ₹15.75 Cr (FY 2025) | Active |
 Atisa Life Sciences Private Limited U24233TG2010PTC071785 | Director | 31 Jul 2025 | 2010 | ₹13.5 Lakh (FY 2025) | Active |
| Serind Pharma Private Limited U74999TG2017PTC116257 | Director | 30 Mar 2017 | 2017 | ₹3.2 Lakh (FY 2020) | Active |
| Vinda Healthcare Private Limited U74999TG2017PTC114312 | Director | 01 Feb 2017 | 2017 | ₹3 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Avidia Pharma Labs Llp ACI-2822 | Designated Partner | 09 Jul 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sandhya Nandiraju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Attili Venkata Satya Suresh | 03439101 | Clinsync Clinical Research Private Limited | Director |
| Koteswara Prasad Sripathipanditaradhyula | 06699849 | Clinsync Clinical Research Private Limited | Director |
| Suresh Kumar Nandiraju | 02548952 | Clinsync Clinical Research Private Limited , Vinda Healthcare Private Limited | Director |
| Somasundaram Shanmugam | 02425917 | Atisa Life Sciences Private Limited | Director |
| Udayalakshmi Suresh | 11196301 | Atisa Life Sciences Private Limited , Serind Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandhya Nandiraju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandhya Nandiraju
Sandhya Nandiraju currently holds 4 directorships: Clinsync Clinical Research Private Limited (Whole-Time Director, since 08 Jan 2018, revenue ₹15.75 Cr (FY 2025)); Atisa Life Sciences Private Limited (Director, since 31 Jul 2025, revenue ₹13.5 Lakh (FY 2025)); Serind Pharma Private Limited (Director, since 30 Mar 2017, revenue ₹3.2 Lakh (FY 2020)); Vinda Healthcare Private Limited (Director, since 01 Feb 2017, revenue ₹3 Lakh (FY 2024)).
Sandhya Nandiraju was first appointed on 01 Feb 2017 as Director at Vinda Healthcare Private Limited. The most recent appointment on record is 31 Jul 2025 at Atisa Life Sciences Private Limited.
The 4 current companies of Sandhya Nandiraju that report revenue have a combined latest revenue of ₹15.95 Cr: Clinsync Clinical Research Private Limited ₹15.75 Cr (FY 2025); Atisa Life Sciences Private Limited ₹13.5 Lakh (FY 2025); Serind Pharma Private Limited ₹3.2 Lakh (FY 2020); Vinda Healthcare Private Limited ₹3 Lakh (FY 2024).
Sandhya Nandiraju held 1 earlier board appointment: Avidia Pharma Labs Llp (Designated Partner, 09 Jul 2024 to 27 Nov 2025).
The current boards of Sandhya Nandiraju's companies include Attili Venkata Satya Suresh (Clinsync Clinical Research Private Limited), Koteswara Prasad Sripathipanditaradhyula (Clinsync Clinical Research Private Limited), Suresh Kumar Nandiraju (Clinsync Clinical Research Private Limited), Somasundaram Shanmugam (Atisa Life Sciences Private Limited), Udayalakshmi Suresh (Atisa Life Sciences Private Limited).